Short answer
ICU MEDICAL INC/DE (ICUI) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $530M (down 12.3% year over year) with net income of $30M.
Q1 2026 key financials · XBRL
- Revenue
- $530M
- −12.3% YoY
- Net income
- $30M
- +294.7% YoY
- Operating margin
- 2.6%
- Gross margin
- 38.9%
- EPS (diluted)
- $1.20
- +290.5% YoY
Source: XBRL data from the ICU MEDICAL INC/DE (ICUI) Q1 2026 10-Q on SEC EDGAR. USD.
ICU MEDICAL INC/DE Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- IV Solutions transferred to joint venture; $211.2M total sales price
- $200.0M of transaction proceeds used to repay Term Loan A in Q2 2025
- Tariff, inflation, freight, currency, interest-rate and geopolitical risks cited as near-term headwinds
Risk Factors
- No risk-factors section provided; filing excerpt contains only Items 2, 5, and 6
- Repurchase authorization $100.0 million, subject to Credit Agreement restrictions
- No shares repurchased during first quarter 2026
- No director or officer adopted, modified, or terminated trading arrangements in the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ICU MEDICAL INC/DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.